Restrictive Cardiomyopathy
12
3
3
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 12 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (12)
Pediatric Cardiomyopathy Mutation Analysis
Healthy-related Quality of Life and Physical Activity of Children With Cardiac Malformations
Early Identification and Treatment of Rare Cardiomyopathy Cohorts
AI-enabled Screening and Diagnosis of Cardiomyopathies Using Coronary CTA
Multimodal and Multidisciplinary Approach to Optimize Diagnostic, Prognostic, and Therapeutic Management of Patients with Non-ischemic Cardiomyopathies and Arrhythmogenic-inflammatory Phenotypes: a Multicenter, Observational, Retrospective and Prospective Registry Study.
Coronary Artery Disease and Coronary Microvascular Disease in Cardiomyopathies Registry
The Genetics of Cardiomyopathy and Heart Failure
Sahlgrenska Cardiomyopathy Project
Risk Stratification in Children and Adolescents With Primary Cardiomyopathy
Genotype-Phenotype Associations in Pediatric Cardiomyopathy (PCM GENES)
An Integrative-"Omics" Study of Cardiomyopathy Patients for Diagnosis and Prognosis in China
Metabolomic Study of All-age Cardiomyopathy